PHYSEO – CLINICAL/STEP 2 VIDEOS 2023

Section 1 – Headache Differential

Section 2 – Vertigo and Lightheadedness Differential

Section 3 – Eye Complaints Differential

Section 4 – Altered Mental Status Differential

Section 5 – Sore Throat Differential

Section 6 – Cough Differential

Section 7 – Shortness of Breath Differential

Section 8 – Chest Pain Differential

Section 9 – Vomiting Differential

Section 10 – Upper Abdominal Pain Differential

Section 11 – Diffuse Abdominal and Flank Pain Differential

Section 12 – Lower Abdominal Pain Differential

Section 13 – Back Pain Differential

Section 14 – Leg Pain Differential

Section 15 – Ankle and Foot Injuries Differential

Section 16 – Fever Differential

Section 17 – Syncope and Pre-Syncope Differential

Section 18 – Weakness Differential

Section 19 – Rash Differential

Section 1 – Abdominal Trauma

Section 2 – Chest Trauma Aortic Injury & Cardiac Contusion

Section 3 – Chest Trauma Pulmonary Contusion & Diaphragmatic Rupture

Section 4 – Chest Trauma Flail Chest & Penetrating Chest Injury

Section 5 – Acute Appendicitis

Section 6 – Abdominal Pain and Acute Abdomen

Section 7 – Burns

Section 8 – Thermal Dysregulation

Section 9 – Environmental Toxicities Anticholinergic Poisoning & Acetylcholinesterase Inhibitor Poisoning

Section 10 – Environmental Toxicities Methanol Poisoning & Ethylene Glycol Poisoning

Section 11 – Drug Ingestion and Antidotes

Section 12 – Metal Toxicity

Section 13 – Inhalation Injury and Carbon Monoxide Poisoning

Section 14 – Methemoglobinemia and Cyanide Poisoning

Section 15 – Animal Bites

Section 16 – Human Bites

Section 17 – Snake Bites

Section 18 – Spider Bites

Section 19 – Immediate & Early Postoperative Fever

Section 20 – Late & Delayed Postoperative Fever

Section 21 – Treatment of Acute Asthma and COPD Exacerbations

Section 1 – Biostatistics Overview

Section 2 – Study Designs

Section 3 – Evaluating Study Quality

Section 4 – Evaluating Significance

Section 5 – Bias and Confounders

Section 6 – Sensitivity and Specificity

Section 7 – PPV and NPV

Section 8 – Incidence, Prevalence, and Likelihood Ratios

Section 9 – Measurements of Risk

1. Emergency Medicine (7)

2. Dermatology (1)

3. Cardiology (16)

4. Hematology & Oncology (2)

5. Renal-GU (5)6. Gastroenterology (12)

7. Endocrinology (3)

8. Musculoskeletal (2)

9. Pulmonary (4)

10. Pediatrics (4)

11. Gynecology (3)

12. Neurology (4)

1. Infectious Disease (34)

2. Dermatology (21)

3. Cardiology (33)

4. Hematology & Oncology (24)

5. Renal-GU (26)

6. Gastroenterology (36)

7. Endocrinology (22)

8. Musculoskeletal (28)

9. Pulmonary (12)

10. Fluids and Electrolytes (5)

Section 1 – Child development – Milestones and Growth

Section 2 – Complications in the Newborn Period – Child Development – Puberty

Section 3 – Glycogen Storage Diseases

Section 5 – Lysosomal Storage Diseases – Krabbe, Gaucher, Hurler, and Hunter Syndromes

Section 6 – Inborn Errors of Metabolism

Section 7 – Complications in the Newborn Period – APGAR Scores and Extracranial Injuries

Section 8 – Complications in the Newborn Period – Neonatal Jaundice

Section 9 – Complications in the Newborn Period – Respiratory Pathologies

Section 10 – GI disease – Hypertrophic Pyloric Stenosis, Intussusception & Malrotation with Volvulus

Section 11 – GI disease – Meckel Diverticulum, Hirschsprung Disease & Necrotizing Enterocolitis

Section 12 – Urology – Cryptorchidism, Vesicoureteral Reflux & Posterior Urethral Valves

Section 13 – Urology- Penile Conditions

Section 14 – Congenital B Cell Immunodeficiencies

Section 15 – Congenital T Cell Immunodeficiencies – DiGeorge Syndrome

Section 16 – Congenital T Cell Immunodeficiencies – Job Syndrome, Hyper-IgE Syndrome & Chronic Mucocutaneous Candidiasis

Section 17 – Congenital Mixed Immunodeficiencies – Severe Combined Immunodeficiency & Wiskott Aldrich Syndrome

Section 18 – Congenital Mixed Immunodeficiencies – Hyper-IgM Syndrome & Ataxia-Telangiectasia

Section 19 – Congenital Phagocyte Defects – Chronic Granulomatous Disease & Myeloperoxidase Deficiency

Section 20 – Congenital Phagocyte Defects – Leukocyte Adhesion Deficiency & Chediak-Higashi Syndrome

Section 21 – Congenital Complement Deficiencies

Section 22 – Juvenile Idiopathic Arthritis

Section 23 – Epiglottitis and Croup

Section 24 – Bacterial Tracheitis, Pertussis and Bronchiolitis

Section 25 – Pneumonia

Section 26 – Neonatal Sepsis, and Meningitis

Section 27 – Viral Exanthems

Section 28 – Well-child Care

Section 30 – Child abuse

Section 31 – Oncology – Acute Lymphoblastic Leukemia

Section 32 – Neuroblastoma and Wilms Tumor

Section 33 – Osteosarcoma and Ewing Sarcoma

Section 34 – Pediatric Neurologic Disease

Section 35 – MSK Disorders – Hip Conditions

Section 36 – MSK disorders – Foot Deformities

Section 37 – MSK Disorders – Orthopedic Injuries

Section 38 – Bilious Vomiting

1. Obstetrics (30)

2. Gynecology (40)

Section 1 – Child Abuse and Neglect

Section 2 – Childhood Behavior and Anxiety Disorders

Section 3 – Childhood and Early-Onset Disorders

Section 4 – Depression

Section 5 – Mania

Section 6 – Anxiety Disorders

Section 7 – Cognition, Orientation, Delirium, and Amnesia

Section 8 – Psychosis

Section 9 – Psychotic Disorders

Section 10 – Dissociative Disorders 

Section 11 – Malingering, Factitious Disorders, and Somatic Disorders

Section 12 – Personality Disorders

Section 13 – Eating Disorder

Section 15 – Sex-Related Disorders

Section 16 – Sleep Disorders

Section 17 – Substance Use Disorders and Stages of Change

Section 18 – Trauma and Stress-Related Disorders

Section 1 – Cerebrovascular Disease – Ischemic Stroke

Section 2 – Cerebrovascular Disease – Cerebral Venous Thrombosis

Section 3 – Movement disorders – Parkinson & Huntington’s Disease

Section 4 – Movement disorders – Tremor & Ataxia

Section 5 – Movement disorders – Restless Leg Syndrome & Tourette Syndrome

Section 6 – Meningitis

Section 7 – Encephalitis

Section 8 – Brain Abscess & Spinal Epidural Abscess

Section 9 – Dementia

Section 10 – Altered Mental Status

Section 11 – Demyelinating Disease

Section 12 – Neuromuscular Diseases

Section 13 – Neurocutaneous Syndromes – Neurofibromatosis Type I, II, and Tuberous Sclerosis

Section 14 – Neurocutaneous Syndromes – Sturge-Weber and von-Hippel-Lindau Syndrome

Section 15 – Spinal Cord Diseases – Anterior Cord Syndrome, Central Cord Syndrome & Brown-Sequard Syndrome

Section 16 – Spinal Cord Diseases – Cauda Equina Syndrome, Syringomyelia & Transverse Myelitis

Section 17 – Spinal Cord Diseases – Poliomyelitis, Amyotrophic Lateral Sclerosis & Horner Syndrome

Section 18 – Seizures – Causes, Types, and Workup

Section 19 – Seizures – Differential Diagnosis, and Management

Section 20 – Aphasia and Neglect

Section 21 – Localizing Neurologic Lesions – Introduction

Section 22 – Localizing Neurologic Lesions – Cerebral Cortex, Subcortex, Brainstem and Cerebellum

Section 23 – Localizing Neurologic Lesions – Spinal Cord, Peripheral Neurons, Neuromuscular Junction, Muscles Diagnosis, & Management

Section 24 – Intracranial Hemorrhage – Subdural & Epidural Hematoma

Section 25 – Intracranial Hemorrhage – Subarachnoid & Intraparenchymal Hemorrhage

Section 26 – Headaches

Section 27 – Nervous System Tumors – Gliomas, Pilocytic Astrocytoma, GB Multiforme

Section 28 – Nervous System Tumors – Oligodendroglioma, Ependymoma

Section 29 – Nervous system tumors – Schwannoma, Medulloblastoma, Hemangioblastoma

Section 30 – Nervous System Tumors – Meningioma, Sellar & Suprasellar Tumor & Secondary Brain Tumors

Section 31 – Dizziness & Vertigo

Section 32 – Syncope

Section 1 – Ethical Principles

Section 2 – Consent and Confidentiality

Section 3 – Capacity

Section 4 – Ethical Situations

Section 5 – Geriatrics

Section 6 – Developmental Milestones

Section 7 – Healthcare Delivery

Section 8 – Quality and Safety

Section 1 – Biostatistics Overview

Section 2 – Study Designs

Section 3 – Evaluating Study Quality

Section 4 – Evaluating Significance

Section 5 – Bias and Confounders

Section 6 – Sensitivity and Specificity

Section 7 – PPV and NPV

Section 8 – Incidence, Prevalence and Likelihood Ratios

Section 9 – Measurements of Risk